Allergy Shots: How They Work, Cost & Whether They're Worth It
Allergy shots (subcutaneous immunotherapy) inject escalating allergen doses to retrain immunity against pollen, dust mites, and pet dander. A 2007 Cochrane review of 51 RCTs found SCIT reduced rhinitis symptoms by a pooled SMD of 0.73 across 2,871 patients. Treatment takes 3-5 years but provides disease-modifying benefits persisting 3-12 years after stopping. With Curex, eligible patients now self-administer these shots at home under allergist supervision.
8 peer-reviewed sources
Allergy shots are the only disease-modifying treatment for IgE-mediated allergic disease, reducing symptoms by roughly one-third and providing lasting relief that persists years after the full 3-5 year course is completed.
What Are Allergy Shots and Who Actually Needs Them?
Allergy shots — the common name for subcutaneous immunotherapy (SCIT) — are the only treatment that directly modifies the underlying immune dysfunction driving allergic disease. Unlike antihistamines or nasal steroids, which suppress symptoms downstream, SCIT delivers escalating doses of the allergen itself under the skin, retraining immune cells to tolerate rather than attack the trigger. That distinction matters: pharmacotherapy stops working when you stop taking it; SCIT changes the immune program itself.
To qualify, patients need demonstrable IgE sensitization confirmed by a positive skin prick test (wheal of at least 3mm above the negative control) or a specific IgE blood test of at least 0.35 kUA/L, combined with symptoms that occur on allergen exposure. Identifying the right allergens before starting is critical — SCIT only works for confirmed IgE-mediated triggers. The first step before any immunotherapy is comprehensive allergy testing. Options like Curex offer at-home test kits covering 40+ allergens with results in about a week, making this diagnostic step more accessible before committing to clinic-based treatment.
The treatment runs in two phases. During the build-up phase (typically 8-28 weeks, once weekly), doses start 100,000-fold (1:100,000) below the target maintenance level and increase incrementally. Once the therapeutic maintenance dose is reached — typically 5-20 micrograms of the major allergen for inhalants, 100 micrograms for stinging insect venom — injections continue on a schedule individualized by your allergist for 3-5 years. Most patients notice meaningful improvement within the first year; disease-modifying benefits require completing the full course.
SCIT is indicated for allergic rhinitis, allergic conjunctivitis, allergic asthma, and Hymenoptera (bee and wasp) venom hypersensitivity. In children with allergic rhinitis, a 3-year SCIT course reduced the risk of developing asthma by half at 10-year follow-up — an effect no pharmacotherapy produces.
Allergy shots are the only disease-modifying treatment for IgE-mediated allergic disease. Unlike medications that only suppress symptoms, SCIT retrains the immune system and can provide lasting relief for 3-12 years after completing the full course.
How Allergy Shots Retrain Your Immune System
The immune cascade behind allergy shots unfolds in precise molecular stages over months to years. Understanding this progression explains why SCIT requires 3-5 years — the benefits cannot be compressed without sacrificing durability. At the core of the SCIT mechanism is a shift from Th2 inflammatory immune responses (which drive allergic reactions) toward regulatory T-cell (Treg)-mediated immune tolerance. This is not a suppression of the immune system — it is a reprogramming that teaches immune cells to ignore harmless allergens. The same pathway is engaged whether allergens are delivered by injection (SCIT) or under the tongue (sublingual immunotherapy), but the route of entry determines the antigen-presenting cells involved and shapes the safety profile.
Allergen Identification and Testing
Before starting SCIT, a board-certified allergist confirms specific IgE sensitization through skin prick testing or blood-based IgE panels. This step is essential — SCIT only modifies sensitivity to allergens that are actually driving your immune response. The testing results determine exactly which allergens are included in the custom injection vial.
Early Immune Desensitization
Within hours of the first injections, histamine receptor 2 (H2R) is upregulated on basophils, suppressing the FcεRI-triggered degranulation that causes immediate allergic symptoms. Within days to weeks, mast cells and basophils become less reactive to allergen exposure. This early desensitization is why some patients notice reduced acute reactions relatively quickly in treatment.
Regulatory T-Cell Expansion
Between 2 and 4 weeks after starting SCIT, FOXP3+ CD25+ regulatory T cells (Tregs) and IL-10-producing Tr1 cells become detectable. These cells produce anti-inflammatory cytokines (IL-10 and TGF-beta) that suppress Th2 immune responses and promote class-switching of B cells from IgE to the non-inflammatory IgG4 antibody. Allergen-specific IgG4 begins rising measurably within 1-3 months.
Long-Term Tolerance and Disease Modification
By 3-12 months, allergen-specific IgG4 has increased 10- to 100-fold. These IgG4 blocking antibodies compete with IgE to bind allergen molecules, preventing the IgE-FcεRI cross-linking that triggers mast cell degranulation and the allergic cascade. Over years of maintenance, tissue eosinophil and mast cell populations fall in target mucosae. After 3-5 years, long-lived plasma cells continue producing IgG4 even after treatment stops — explaining the 3-12 year persistence of benefits.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
The Allergy Shot Treatment Timeline: What to Expect Month by Month
The allergy shot timeline divides into three distinct stages, each with its own visit frequency, expectations, and milestones. Understanding this schedule upfront is essential: over a 3-year course, most patients will make 57-60 clinic visits and spend approximately 110 hours in the allergist's office. That is a genuine commitment — planning around work schedules, childcare, and travel before starting significantly improves completion rates.
During build-up, you receive one injection per visit on a schedule that increments the allergen dose each time. Starting at 100,000-fold (1:100,000) below the target maintenance dose, the extract concentration and volume increase over approximately 25-30 injections. After every injection, a mandatory 30-minute observation period in the office is required — approximately 85% of systemic reactions occur within 30 minutes, making this wait non-negotiable. Faster alternatives include cluster protocols (multiple injections per visit, reaching maintenance in 4-8 weeks) and rush protocols (1-3 days under close supervision with premedication).
Once the therapeutic maintenance dose is reached, injection frequency drops to on a schedule individualized by your allergist. The same 30-minute post-injection observation applies at every visit. During this phase, the immune system consolidates the tolerance it has been building — IgG4 blocking antibodies continue rising, Treg populations stabilize, and tissue mast cell and eosinophil counts fall. Disease benefits accumulate progressively. If you must miss appointments, dose adjustments are required based on the gap length — contact your Curex care team before resuming after any gap of more than two weeks, as the resumption dose is always set by the clinical team, not self-adjusted.
Most patients notice meaningful symptom improvement within 3-6 months of reaching maintenance, with full benefit at 2-3 years. After completing a 3-5 year course, disease-modifying effects persist for an average of 3-12 years without further injections — confirmed by Durham et al. (NEJM 1999) and a 12-year pediatric follow-up by Eng et al. (Allergy 2006). In children, a completed SCIT course reduces the risk of developing asthma by approximately half, an effect that persisted at 10-year follow-up in the PAT study (Jacobsen et al., Allergy 2007).
Allergy Shot Efficacy: What the Clinical Trials Actually Show
The evidence base for allergy shots is among the strongest in all of allergy medicine, built on over 100 randomized controlled trials and multiple systematic Cochrane reviews. The headline finding — a one-third reduction in symptoms compared with placebo — is clinically meaningful but more modest than many patient-facing materials suggest. Context matters: this one-third reduction is sustained and disease-modifying, while comparable pharmacotherapy benefits disappear when medication stops. Response rates vary substantially by allergen. Grass pollen and dust mites have the strongest evidence; cat dander and ragweed for rhinitis are well-established; dog dander has weaker evidence due to extract standardization problems; cockroach SCIT failed its primary clinical endpoint in the most rigorous recent trial (CRITICAL, 2024).
Success Rate by Duration
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youAllergy Shots vs. Other Treatments: An Evidence-Based Comparison
Allergy shots occupy a unique position in the treatment landscape because they are the only option proven to modify the underlying disease — not just suppress symptoms. Pharmacotherapy (antihistamines, nasal corticosteroids, leukotriene antagonists) provides comparable or better short-term symptom control while you are taking it, but offers no benefit after stopping. Sublingual immunotherapy (SLIT) delivers similar disease-modifying mechanisms through the oral mucosa rather than by injection, with network meta-analyses showing comparable efficacy for grass pollen and dust mites and a markedly better safety profile. The practical tradeoffs — time, cost, needles, clinic access — often matter more than modest efficacy differences.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
Allergy Shots (SCIT)Best | Reduces symptoms by ~33% vs placebo; disease-modifying benefits persist 3-12 years after stopping | 3-5 years (57-60 clinic visits) | $4,500-$10,000+ | Weekly clinic visits during build-up (6 months), biweekly-to-on an individualized schedule thereafter; 30-minute wait required at every visit | Systemic reactions in 0.1% of injections; ~7 confirmed fatalities in 54.4 million US injection visits 2008-2016 |
Sublingual Drops (SLIT) | Comparable efficacy to SCIT for grass and dust mites per network meta-analysis; same disease-modifying mechanisms | 3-5 years (daily at-home drops) | $2,000-$6,000 | Daily 1-2 minute at-home dosing; no injections, no waiting rooms, no clinic visits for maintenance | Zero confirmed fatalities worldwide; systemic anaphylaxis estimated at <1 per 100 million doses |
Antihistamines (OTC) | Reduces histamine-mediated symptoms only; no disease modification; efficacy stops when medication stops | Ongoing as needed | $300-$1,200 | Daily pills; available over the counter without prescription | Non-sedating options have excellent safety profiles; no anaphylaxis risk |
Nasal Corticosteroids | Most effective single pharmacotherapy for nasal symptoms; ~32% symptom reduction comparable to SCIT on active medication | Ongoing during allergy seasons | $500-$2,500 | Daily nasal spray; available OTC (fluticasone, triamcinolone) or by prescription | Excellent safety profile; minimal systemic absorption at standard doses |
- Efficacy
- Reduces symptoms by ~33% vs placebo; disease-modifying benefits persist 3-12 years after stopping
- Duration
- 3-5 years (57-60 clinic visits)
- Cost (5yr)
- $4,500-$10,000+
- Convenience
- Weekly clinic visits during build-up (6 months), biweekly-to-on an individualized schedule thereafter; 30-minute wait required at every visit
- Safety
- Systemic reactions in 0.1% of injections; ~7 confirmed fatalities in 54.4 million US injection visits 2008-2016
- Efficacy
- Comparable efficacy to SCIT for grass and dust mites per network meta-analysis; same disease-modifying mechanisms
- Duration
- 3-5 years (daily at-home drops)
- Cost (5yr)
- $2,000-$6,000
- Convenience
- Daily 1-2 minute at-home dosing; no injections, no waiting rooms, no clinic visits for maintenance
- Safety
- Zero confirmed fatalities worldwide; systemic anaphylaxis estimated at <1 per 100 million doses
- Efficacy
- Reduces histamine-mediated symptoms only; no disease modification; efficacy stops when medication stops
- Duration
- Ongoing as needed
- Cost (5yr)
- $300-$1,200
- Convenience
- Daily pills; available over the counter without prescription
- Safety
- Non-sedating options have excellent safety profiles; no anaphylaxis risk
- Efficacy
- Most effective single pharmacotherapy for nasal symptoms; ~32% symptom reduction comparable to SCIT on active medication
- Duration
- Ongoing during allergy seasons
- Cost (5yr)
- $500-$2,500
- Convenience
- Daily nasal spray; available OTC (fluticasone, triamcinolone) or by prescription
- Safety
- Excellent safety profile; minimal systemic absorption at standard doses
For patients who want the disease-modifying benefits of allergy shots without 57-60 clinic visits, Curex delivers the shot itself at home for $129/month — a personalized SCIT serum sterile-compounded to USP <797>, prescribed by a board-certified allergist, engaging the same Treg-mediated tolerance pathway. You self-administer one weekly injection following the same gradual dose-escalation protocol clinics use, with a prescribed epinephrine auto-injector confirmed on hand and the first injection from each new vial or concentration supervised live in the Virtual Shot Room.
See if at-home shots are right for youAllergy Shot Safety: A Spectrum from Normal to Emergency
Allergy shots are given in a medical office specifically because of the small but real risk of systemic allergic reactions — including anaphylaxis. The mandatory 30-minute post-injection observation period is not bureaucratic caution; approximately 85% of systemic reactions occur within 30 minutes of injection. Understanding the full safety spectrum helps patients recognize what is normal, what to monitor, and when to seek immediate help. The vast majority of reactions are local and minor. Systemic reactions occur in roughly 0.1% of all injection visits, and fatal reactions are extremely rare — 7 confirmed fatalities across 54.4 million US injection visits from 2008-2016. The most important risk factor for serious reactions is uncontrolled asthma: patients with FEV1 below 70% predicted should not receive injections that day.
When to Worry: Decision Guide
Is the reaction limited to the injection site only?
Local reaction — expected
Apply ice. Monitor size. Report to allergist if larger than golf ball or recurring. No emergency action needed.
Systemic reaction — act now
Use your prescribed epinephrine auto-injector if symptoms are systemic, call 911, and notify your care team immediately.
Are you having difficulty breathing, throat tightening, or dizziness?
Potential anaphylaxis — emergency
Use epinephrine auto-injector immediately. Call 911. Do not drive yourself. Stay in a supervised setting.
Mild systemic reaction
Notify your care team and keep self-monitoring with your epinephrine auto-injector on hand. An antihistamine or epinephrine may be appropriate as your allergist determines — live in the Virtual Shot Room on a supervised dose; use epinephrine and call 911 if symptoms progress.
What Allergy Shots Actually Cost in 2025: Insurance, Self-Pay, and Hidden Costs
Allergy shot costs vary substantially based on insurance coverage, geographic location, and whether you need testing first. With commercial insurance, most patients pay $15-50 per visit in copays — which adds up to $3,000-5,000+ over a 3-year course just in copays, before factoring in deductibles and serum fees. Without insurance, annual SCIT costs range from $1,000-4,000 depending on region. The indirect costs are frequently underestimated. A full 3-year SCIT course requires approximately 57-60 clinic visits and about 110 hours of total patient time. At the average US wage, that translates to $1,500-3,000 in lost wages — a cost that pharmacoeconomic analyses rarely capture but patients feel acutely. Cost-effectiveness analyses consistently show that completed SCIT courses save healthcare dollars over 18-month to 10-year horizons by reducing rescue medication use, urgent care visits, and hospitalizations.
| Item | Medicare | With Insurance | Self-Pay |
|---|---|---|---|
| Initial Allergy Testing | $0-50 | $20-150 | $150-500 |
| Extract Preparation (Annual) | $0-30 | $20-100 | $450-600 |
| Injection Administration (per visit) | $15-25 | $15-50 | $20-100 |
| Year 1 Total (Build-Up + Maintenance) | $400-800 | $800-2,000 | $2,000-5,000 |
| Years 2-3 Annual (Maintenance) | $200-400 | $400-1,000 | $1,000-3,000 |
| Total (5 years) | $1,200-2,400 | $2,400-6,000 | $5,000-15,000 |
5-Year Cost Comparison
- Lost wages from weekly office visits — 57-60 visits over 3 years at 1.5-2 hours each = $1,500-3,500 in foregone work time at average US wages
- Travel and parking costs — urban patients average 30-60 minutes round-trip per visit; rural patients may face 60-120+ minute drives
- Childcare during build-up appointments — weekly visits for 6 months require consistent care arrangements
- Insurance deductibles and out-of-pocket maximums applied before copays kick in — initial year costs can be substantially higher
- Dose restart costs if treatment is interrupted — significant gaps in maintenance require provider-directed dose reduction or restart, extending the total treatment course; the resumption dose is always determined by the Curex clinical team
Does Insurance Cover Allergy Shots? Coverage by Insurer
Most major US health insurance plans cover allergy shots as a medically necessary treatment for allergic rhinitis, allergic asthma, and stinging insect hypersensitivity. Coverage is typically subject to prior authorization, step therapy requirements (demonstrating failure of medications first), and cost-sharing through copays and deductibles. Medicare Part B covers allergy immunotherapy under the physician services benefit, with 20% coinsurance after the annual deductible. Medicaid coverage varies by state. Key billing codes determine reimbursement: CPT 95165 covers professional allergen immunotherapy services, while 95115 and 95117 cover the actual injection administration. Most insurers require the treatment to be administered in an allergist's office by or under the supervision of a board-certified physician.
Copay: $15-50/visit
Prior auth required
Prior authorization required; step therapy may require documented failure of 2+ medications
Copay: $20-50/visit
Prior auth required
Coverage varies by state plan; prior auth commonly required for build-up phase
Copay: $15-40/visit
Prior auth required
Medical necessity documentation required; IgE sensitization confirmation required
Copay: $20-50/visit
Prior auth required
Step therapy often required; diagnosis must correlate with test results
Copay: $15-45/visit
Prior auth required
Prior authorization required; office visits billed separately from extract preparation
Copay: $10-30/visit
In-network only; administered in Kaiser allergy department
Copay: 20% coinsurance
20% coinsurance after $257 deductible (2025); must be administered by Medicare-enrolled provider
Copay: $0-5/visit
Prior auth required
Coverage and copays vary by state; many states require prior authorization
Skip the insurance hassle — Curex is $129/mo flat, no insurance needed.
Start free assessmentFrequently asked questions
How long do allergy shots take to work?
Most patients notice meaningful symptom improvement within 3-6 months of reaching the maintenance dose, though some require up to 12 months before clear benefit emerges. The AAAAI/ACAAI Practice Parameter states that clinical improvement is usually observed within one year after reaching maintenance. Initial small improvements may appear during the build-up phase itself, but significant relief typically correlates with sustained maintenance dosing. If no benefit is noticeable after 12 full months at the maintenance dose, your allergist should reassess allergen selection, dosing, and whether SCIT is the right approach for your specific triggers. Patience is genuinely required — attempting to judge effectiveness at 2-3 months of treatment is premature. Full disease-modifying benefit accumulates over the entire 3-5 year treatment course.
How often do you get allergy shots?
During the build-up phase, allergy shots are typically administered once weekly for 3-6 months. Some patients use a cluster protocol, receiving 2-3 injections on the same day to reach maintenance more quickly in 4-8 weeks. During the maintenance phase, injections drop to on a schedule individualized by your allergist and continue for 3-5 years. After each injection you self-monitor for 30 minutes with your prescribed epinephrine auto-injector on hand — about 45 minutes start to finish. With at-home SCIT you self-administer these doses rather than traveling to a clinic, while the first injection from each new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff. After completing the full treatment course, no further injections are typically required unless symptoms return years later.
Are allergy shots worth it?
Clinical evidence strongly supports allergy shots for patients with moderate-to-severe allergic rhinitis, allergic asthma, or stinging insect hypersensitivity who have confirmed IgE sensitization to relevant allergens. Meta-analyses show a roughly one-third reduction in symptoms versus placebo, and uniquely, benefits persist 3-12 years after completing the treatment course — no pharmacotherapy provides this. For children with hay fever, a 3-year course cut the 10-year risk of developing asthma by approximately half. The main limitation is the substantial time commitment: 57-60 clinic visits over 3 years, approximately 110 hours of total patient time. Studies show only 23% of patients complete the recommended 3-year course in real-world settings. For patients who can maintain the schedule, the evidence strongly supports long-term value.
Can allergy shots make allergies worse?
Allergy shots do not make allergies permanently worse, but they can temporarily provoke symptoms during the build-up phase. Local reactions at the injection site — redness, swelling, and itching — occur in 26-86% of patients and reflect expected immune activation. Mild systemic reactions (sneezing, hives, mild wheezing) occur in roughly 0.1% of injection visits. These are signs that the immune system is responding, not evidence of worsening long-term allergy. Dosing during peak pollen season can increase reaction risk for seasonal allergen-sensitive patients, which is why some allergists temporarily reduce doses at the height of the season. Genuine worsening of allergy without provocation — outside the injection observation period — is not an expected or documented effect of SCIT.
What happens if you miss an allergy shot?
Missed allergy shots require dose adjustments that depend on how long the gap was. Curex follows a 6-tier missed-dose protocol: gaps of 6–10 days allow continuing at the planned dose; 11–14 days repeat the last dose; 15–21 days step back one concentration level; 22–28 days during build-up require provider review and stepping back two levels; gaps over 28 days require a hold and provider review — the resumption dose is set by the Curex clinical team. Patients must never self-adjust or self-restart after a missed-dose gap. Always contact your Curex care team before your next injection after any gap longer than two weeks.
Do allergy shots work for food allergies?
Allergy shots (SCIT) are not an approved or recommended treatment for food allergies. Food allergy immunotherapy uses a different route — oral immunotherapy (OIT) — which involves consuming gradually increasing amounts of the food allergen under medical supervision. The FDA has approved OIT for peanut allergy (Palforzia, 2020), where 67.2% of treated patients tolerated 600mg peanut protein versus 4% on placebo in the PALISADE trial. For other food allergens like tree nuts, milk, and egg, OIT is available at specialized centers but without FDA approval. SCIT is specifically indicated for inhalant allergens (pollens, dust mites, animal danders, molds) and stinging insect venom, where the IgE sensitization is confirmed and exposure is airborne or sting-based rather than ingestion-based.
How long do allergy shot benefits last after stopping?
Research suggests that completing a 3-5 year course of allergy shots produces disease-modifying benefits that persist for 3-12 years after discontinuation. The foundational study (Durham et al., NEJM 1999) showed that patients who completed 3-4 years of grass pollen SCIT maintained symptom and medication scores as low as patients continuing treatment for at least 3 years post-discontinuation. A 12-year pediatric follow-up (Eng et al., Allergy 2006) found significant clinical benefit a decade after childhood SCIT. The critical qualifier is treatment duration: clinical trial data show 2-year courses are insufficient for lasting post-treatment benefit (Scadding et al., JAMA 2017), while 3-year courses produce durable results. Benefits tend to be more durable in monosensitized patients and those who started treatment younger.
Are allergy shots safe during pregnancy?
The AAAAI/ACAAI Practice Parameter states that allergy immunotherapy can be continued but is generally not initiated during pregnancy. If you are already on maintenance immunotherapy and tolerating it well before becoming pregnant, continuing at your current dose throughout pregnancy is generally considered safe — dose increases should be avoided. The rationale for not starting during pregnancy is the risk of systemic reactions during the build-up phase, which could potentially cause fetal hypoxia or trigger uterine contractions. The largest safety study to date (Mitselou et al., 2022, covering 743 AIT-exposed pregnancies in Swedish registries) found no increased risk of congenital malformations, preterm birth, or stillbirth. Always discuss your specific situation with both your allergist and your OB/GYN before making any changes during pregnancy.
Related Articles
Allergy Shots for Cat Allergy | Full SCIT Guide | Curex
Allergy shots for cat allergies reduce symptoms 60-72% at the 15 mcg Fel d 1 maintenance dose. Cat SCIT efficacy, dosing, and alternatives.
Read moreWhat Is Allergy Shots? Quick Definition and How It Works
What is allergy shots? SCIT trains your immune system to tolerate allergens over 3-5 years. 85-90% of patients see significant improvement.
Read moreAllergy Shot Side Effects: Per-Injection Timeline | Curex
What happens after each allergy shot? A minute-by-minute timeline from the 30-min wait to 48-hour local reactions, with safety thresholds and real data.
Read moreLong-Term Side Effects of Allergy Shots | Safety | Curex
Long-term side effects of allergy shots: aluminum exposure, organ safety, fatigue, and post-treatment durability reviewed with real surveillance data.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreDo Allergy Shots Work? Evidence & Honest Verdict | Curex
Do allergy shots work? Meta-analyses of 51 RCTs show 33-85% symptom reduction — but 20-50% of patients are low responders. Here's the honest evidence.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.